Authors
Loading...
Biosensor differentiates pathogenic KKO from nonpathogenic RTO antibodies, highlighting FcγRIIA interactions.
Zheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: